Skip to main content
Premium Trial:

Request an Annual Quote

New York State Clears Pathway Genomics' Weight Management Gene Test

NEW YORK (GenomeWeb News) – Pathway Genomics said today that it has received a Clinical Laboratory Permit from the New York State Department of Health for healthcare providers to offer the Pathway Fit genetic test in the state.

The Pathway Fit tests for genes associated with food metabolism and response to exercise, and is used to provide "actionable recommendations" to help people lose weight, maintain a healthy weight, and tailor their diets based on genetics, the company said.

The laboratory of San Diego-based Pathway received a CLIA Certificate of Accreditation in 2011 from the Centers for Medicare and Medicaid Services. A handful of states require additional regulatory approval for certain tests to be offered to patients from those states, however.

During the summer, Pathway announced a deal with Parkway Laboratory Service to offer the Fit test in Singapore.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.